Mizuho Issues Positive Forecast for BrightSpring Health Services (NASDAQ:BTSG) Stock Price

BrightSpring Health Services (NASDAQ:BTSG) had its price target upped by Mizuho from $45.00 to $50.00 in a research report released on Tuesday,Benzinga reports. Mizuho currently has an outperform rating on the stock.

A number of other brokerages have also commented on BTSG. BMO Capital Markets reissued an “outperform” rating and issued a $46.00 price target on shares of BrightSpring Health Services in a report on Friday, January 23rd. BTIG Research reissued a “buy” rating and issued a $55.00 target price on shares of BrightSpring Health Services in a research note on Monday. Zacks Research downgraded BrightSpring Health Services from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Wall Street Zen lowered BrightSpring Health Services from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 15th. Finally, KeyCorp upgraded BrightSpring Health Services from a “sector weight” rating to an “overweight” rating and set a $45.00 price objective for the company in a report on Friday, December 12th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, BrightSpring Health Services has a consensus rating of “Moderate Buy” and a consensus price target of $42.85.

BrightSpring Health Services Price Performance

Shares of NASDAQ BTSG opened at $40.65 on Tuesday. The stock’s 50-day simple moving average is $39.26 and its two-hundred day simple moving average is $33.67. BrightSpring Health Services has a twelve month low of $15.48 and a twelve month high of $44.87. The firm has a market capitalization of $7.87 billion, a P/E ratio of 46.19, a P/E/G ratio of 0.65 and a beta of 2.31. The company has a quick ratio of 1.12, a current ratio of 1.57 and a debt-to-equity ratio of 1.32.

BrightSpring Health Services (NASDAQ:BTSG) last issued its quarterly earnings results on Friday, February 27th. The company reported $0.33 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.01). The business had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.38 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The business’s revenue was up 29.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.11 EPS. As a group, equities analysts anticipate that BrightSpring Health Services will post 0.59 EPS for the current fiscal year.

Institutional Investors Weigh In On BrightSpring Health Services

Several institutional investors have recently bought and sold shares of the stock. Lisanti Capital Growth LLC bought a new stake in BrightSpring Health Services during the 3rd quarter valued at $1,959,000. Federated Hermes Inc. raised its holdings in shares of BrightSpring Health Services by 44.8% during the third quarter. Federated Hermes Inc. now owns 319,200 shares of the company’s stock valued at $9,436,000 after acquiring an additional 98,745 shares in the last quarter. Prescott Group Capital Management L.L.C. bought a new position in shares of BrightSpring Health Services during the third quarter valued at approximately $887,000. Ellsworth Advisors LLC purchased a new stake in BrightSpring Health Services in the third quarter worth about $983,000. Finally, Bailard Inc. bought a new position in shares of BrightSpring Health Services in the 3rd quarter worth approximately $378,000.

Key BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Mizuho raised its price target on BTSG from $45 to $50 and maintained an “outperform” rating, signaling stronger analyst confidence and a material upside to current levels. Article Title
• Positive Sentiment: Wells Fargo boosted its price target from $43 to $50 and assigned an “overweight” rating, reinforcing the bullish analyst view and likely supporting demand at current prices. Article Title
• Neutral Sentiment: A Zacks comparison piece examines BTSG versus peer Caris Life Sciences (CAI) for value-oriented investors; this is a general research/idea piece rather than a company-specific catalyst. BTSG vs. CAI: Which Stock Is the Better Value Option?
• Neutral Sentiment: Company press releases announce a concurrent share repurchase alongside the planned secondary sale; management intends buyback activity, but details/timing relative to the secondary sale are unclear. BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
• Neutral Sentiment: Short-interest data reported for early March appears internally inconsistent (zeros and NaN values) and is likely a reporting error — it does not provide a meaningful signal to explain today’s move.
• Negative Sentiment: Selling stockholders priced a large secondary offering of 20,000,000 shares at $41.15 per share; BrightSpring is not selling any new shares and selling stockholders receive the proceeds. The size (20M shares) versus typical daily turnover can increase supply pressure and likely weighed on the stock today. BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.